Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects

NCT02682901 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Autonomic Neuropathy

Interventions

DRUG: Cycloset
DRUG: Placebo

Sponsor

Eastern Virginia Medical School